Eldon Spackman

4.5k total citations · 1 hit paper
102 papers, 2.7k citations indexed

About

Eldon Spackman is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology. According to data from OpenAlex, Eldon Spackman has authored 102 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 21 papers in General Health Professions and 17 papers in Epidemiology. Recurrent topics in Eldon Spackman's work include Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical Economics and Policy (9 papers) and Spondyloarthritis Studies and Treatments (8 papers). Eldon Spackman is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical Economics and Policy (9 papers) and Spondyloarthritis Studies and Treatments (8 papers). Eldon Spackman collaborates with scholars based in Canada, United Kingdom and United States. Eldon Spackman's co-authors include Sebastian Hinde, Marta Soares, Sean D. Sullivan, Mark Sculpher, Karl Claxton, Peter Smith, Nigel Rice, Nancy Devlin, Nicolas Iragorri and Fiona Clement and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eldon Spackman

90 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

2015 511 citations Karl Claxton, Marta Soares et al. Health Technology Assessment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eldon Spackman Canada	26	746	578	326	309	304	102	2.7k
Tammy Clifford Canada	28	316 0.4×	412 0.7×	341 1.0×	275 0.9×	384 1.3×	71	3.7k
Moustapha Dramé France	30	356 0.5×	573 1.0×	391 1.2×	165 0.5×	338 1.1×	208	2.8k
Rajesh Balkrishnan United States	36	526 0.7×	571 1.0×	266 0.8×	262 0.8×	803 2.6×	158	4.6k
Peter K. K. Wong Australia	21	503 0.7×	296 0.5×	128 0.4×	233 0.8×	260 0.9×	64	3.3k
Tracey Young United Kingdom	37	1.5k 2.1×	873 1.5×	227 0.7×	228 0.7×	452 1.5×	108	4.0k
Ruth E. Brown Canada	35	851 1.1×	433 0.7×	635 1.9×	369 1.2×	410 1.3×	109	3.7k
Zoltán Vokó Hungary	30	295 0.4×	394 0.7×	217 0.7×	233 0.8×	340 1.1×	153	2.9k
David Wonderling United Kingdom	25	724 1.0×	385 0.7×	186 0.6×	208 0.7×	288 0.9×	47	3.1k
Agnès Dechartres France	38	678 0.9×	417 0.7×	415 1.3×	682 2.2×	591 1.9×	149	4.7k
Nancy A Dreyer United States	32	813 1.1×	297 0.5×	158 0.5×	398 1.3×	549 1.8×	135	3.6k

Countries citing papers authored by Eldon Spackman

Since Specialization

Citations

This map shows the geographic impact of Eldon Spackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eldon Spackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eldon Spackman more than expected).

Fields of papers citing papers by Eldon Spackman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eldon Spackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eldon Spackman. The network helps show where Eldon Spackman may publish in the future.

Co-authorship network of co-authors of Eldon Spackman

This figure shows the co-authorship network connecting the top 25 collaborators of Eldon Spackman. A scholar is included among the top collaborators of Eldon Spackman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eldon Spackman. Eldon Spackman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rennert‐May, Elissa, Braden Manns, Fiona Clement, et al.. (2025). Cost-Effectiveness of Semaglutide in Patients With Obesity and Cardiovascular Disease. Canadian Journal of Cardiology. 41(1). 128–136. 4 indexed citations

Wiens, Kathryn, Bai Li, Paul E. Ronksley, et al.. (2025). The Impact of Homelessness on Kidney Outcomes Among Adults With Diabetes. Kidney International Reports. 11(2). 103707–103707.

McHugh, Neil, Laura Bojke, Laura C. Coates, et al.. (2023). OP0271 INCIDENCE OF PSORIATIC ARTHRITIS AND PREVALENCE OF UNDIAGNOSED CASES IN A UK PRIMARY CARE POPULATION FOLLOWED PROSPECTIVELY FOR 2 YEARS - RESULTS FROM THE TUDOR RANDOMIZED CLINICAL TRIAL. Annals of the Rheumatic Diseases. 82. 178–179.

Helliwell, Philip, Laura C. Coates, Jon Packham, et al.. (2023). The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study. Lara D. Veeken. 63(4). 991–998. 2 indexed citations

Paulden, Mike, Chris Sampson, James F. O’Mahony, et al.. (2023). Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained. Value in Health. 27(3). 356–366. 3 indexed citations

Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2022). The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 14. 27 indexed citations

Ben‐Israel, David, Michael Yang, Albert M. Isaacs, et al.. (2022). Clinical outcomes in pediatric hydrocephalus patients treated with endoscopic third ventriculostomy and choroid plexus cauterization: a systematic review and meta-analysis. Journal of Neurosurgery Pediatrics. 30(1). 18–30. 6 indexed citations

Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2021). OA16.02 The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(10). S876–S876. 3 indexed citations

Campbell, David J.T., Yewande Kofoworola Ogundeji, Flora Au, et al.. (2021). First‐line pharmacotherapy for incident type 2 diabetes: Prescription patterns, adherence and associated costs. Diabetic Medicine. 38(9). e14622–e14622. 17 indexed citations

10.

Chew, Derek S., Elissa Rennert‐May, F. Russell Quinn, et al.. (2020). Economic evaluation of extended electrocardiogram monitoring for atrial fibrillation in patients with cryptogenic stroke. International Journal of Stroke. 16(7). 809–817. 6 indexed citations

11.

Spackman, Eldon, et al.. (2019). Do Corporate Fiduciary Duties Matter?. RePEc: Research Papers in Economics. 4(4). 272–326. 4 indexed citations

12.

Iragorri, Nicolas, Glen Hazlewood, Braden Manns, Vishva M. Danthurebandara, & Eldon Spackman. (2018). Psoriatic arthritis screening: a systematic review and meta-analysis. Lara D. Veeken. 58(4). 692–707. 41 indexed citations

13.

Spackman, Eldon, Sebastian Hinde, Laura Bojke, Katherine Payne, & Mark Sculpher. (2017). Using Cost-Effectiveness Analysis to Quantify the Value of Genomic-Based Diagnostic Tests: Recommendations for Practice and Research. Genetic Testing and Molecular Biomarkers. 21(12). 705–716. 8 indexed citations

14.

MacPherson, Hugh, Andrew J. Vickers, Martin Bland, et al.. (2017). Acupuncture for chronic pain and depression in primary care: a programme of research. SHILAP Revista de lepidopterología. 5(3). 1–316. 39 indexed citations

15.

Hinde, Sebastian, Ros Wade, Stephen Palmer, Nerys Woolacott, & Eldon Spackman. (2016). Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the Evidence. PharmacoEconomics. 34(6). 587–596. 2 indexed citations

16.

Spackman, Eldon, Stewart Richmond, Mark Sculpher, et al.. (2014). Cost-Effectiveness Analysis of Acupuncture, Counselling and Usual Care in Treating Patients with Depression: The Results of the ACUDep Trial. PLoS ONE. 9(11). e113726–e113726. 25 indexed citations

17.

Claxton, Karl, Stephen Palmer, Louise Longworth, et al.. (2012). Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technology Assessment. 16(46). 1–323. 78 indexed citations

18.

Griffin, Susan, Eldon Spackman, Marta Soares, Claire McKenna, & Karl Claxton. (2012). PRM168 An Integrated Formal Framework for Reimbursement, Research and Pricing Deliberations in Health Technology Assessment. Value in Health. 15(7). A491–A491. 1 indexed citations

19.

Norman, Gill, Stephen Rice, Eldon Spackman, et al.. (2011). Trastuzumab for the treatment of HER2- positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Health Technology Assessment. 15(Suppl 1). 33–42. 11 indexed citations

20.

Campbell, Jonathan D., Eldon Spackman, & Sean D. Sullivan. (2010). The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy. 65(9). 1141–1148. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact